Researcher in Focus - Jozef Gécz

Jozef Gezc #2.PNG

Jozef Gécz has long been a mover and shaker in the field of genomics.

Jozef Gécz, PhD is National Health and Medical Research Council Senior Principal Research Fellow and Channel 7 Inaugural Chair for the Prevention of Childhood Disability at the University of Adelaide and South Australian Health and Medical Research Institute.

Jozef’s career spans 32 years of competitive research in genomics and molecular biology of childhood onset neurological disorders across three countries, Slovakia, France and Australia.

Jozef arrived to Adelaide in 1994 to join the team of Prof Grant Sutherland at the WCH Hospital and with research focus on molecular genetics and mechanisms of intellectual disability. After initial success with the identification of the first non-syndromic intellectual disability gene FMR2 or bone dysplasia gene TRAPPC2 Jozef discovered or contributed to the discovery of >200 disease genes. His research interest expanded to include genetics of other neurodevelopmental disabilities, that is childhood onset epilepsies (e.g. PCDH19, CDKL5, TBC1D24), autisms (e.g. UPF3B) and more recently a specific group of movement disorders, that is cerebral palsies (first whole exome sequencing study). Jozef’s achievements have been recognised, among others, also by Fellowships of the Australian Academy of Science, Australian Academy of Health and Medical Sciences and the Faculty of Science of the Royal College of Pathologists of Australasia.

Jozef is one of the Chief Investigators and member of the National Steering Committee of the NHMRC Funded Australian Genomics effort. Jozef’s research is patient driven and patient centric. It focuses on the application of genomics for early and precise diagnosis of neurodevelopmental disabilities to empower early intervention and personalised management and treatment.